University of Tsukuba · Faculty of Medicine

Research keywordsmetastatic urothelial carcinoma・renal cell carcinoma・nivolumab plus ipilimumab・enfortumab vedotin・bladder cancer・antitumor immunity・partial nephrectomy・juxtaglomerular cell tumor

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study2026 · 論文
• Impact of European Association of Urology Combination and Platinum Eligibility on Real-World Treatment Sequences and Survival in Japanese Patients With Metastatic Urothelial Carcinoma2026 · 論文
• Systemic administration of liposomal trehalose dimycolate induces NK1.1⁺ cell mediated antitumor immunity in bladder cancer2026 · 論文
• Blood parameters and whole-blood transcriptomics associated with immune-related adverse events in metastatic renal cell carcinoma during nivolumab plus ipilimumab2026 · 論文

• エチレングリコール付加スクワレンによるがん治療の臨床応用への基盤構築2023 · 日本学術振興会/基盤研究(C)
• 骨格筋間質由来幹細胞移植による膀胱機能障害に対する新治療法の開発2018 · 日本学術振興会/基盤研究(C)

• Official profile